{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "C106A",
        "Protein_Change": {
          "ref": "C",
          "alt": "A",
          "position": "106"
        },
        "variant_string_id": "C106A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The article focuses on DJ-1 mutations and their effects on protein stability and activity",
          "judgment": "No",
          "reasoning": "No explicit statement about the disease mechanism or the function of DJ-1 within it"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper does not provide sufficient information about the disease mechanism, so we cannot evaluate the applicability of the general assay class",
          "judgment": "No",
          "reasoning": "Cannot evaluate applicability of the general assay class without knowing the disease mechanism",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not mention specific controls or replicates used in the experiments",
          "judgment": "No",
          "reasoning": "Cannot evaluate validity of specific instances of assays without information on basic controls and replicates",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The paper does not mention any specific validation studies or commercial kits used for the assays, but provides detailed methods and results, suggesting that the assays are standard techniques in the field",
          "judgment": "Yes",
          "reasoning": "Assuming that the assays are broadly accepted in the field",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "Max PS3_supporting / Max BS3_supporting"
      },
      "overall_conclusion": "The functional evidence for the C106A variant is considered Max PS3_supporting / Max BS3_supporting, as the paper does not provide sufficient information to make a more definitive assessment. However, the lack of explicit statements about the disease mechanism and the use of variant controls weaken the evidence strength."
    },
    {
      "variant_id": {
        "Gene": "M26I",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The article focuses on DJ-1 mutations and their effects on protein stability and activity",
          "judgment": "No",
          "reasoning": "No explicit statement about the disease mechanism or the function of DJ-1 within it"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper does not provide sufficient information about the disease mechanism, so we cannot evaluate the applicability of the general assay class",
          "judgment": "No",
          "reasoning": "Cannot evaluate applicability of the general assay class without knowing the disease mechanism",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not mention specific controls or replicates used in the experiments",
          "judgment": "No",
          "reasoning": "Cannot evaluate validity of specific instances of assays without information on basic controls and replicates",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The paper does not mention any specific validation studies or commercial kits used for the assays, but provides detailed methods and results, suggesting that the assays are standard techniques in the field",
          "judgment": "Yes",
          "reasoning": "Assuming that the assays are broadly accepted in the field",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "Max PS3_supporting / Max BS3_supporting"
      },
      "overall_conclusion": "The functional evidence for the M26I variant is considered Max PS3_supporting / Max BS3_supporting, as the paper does not provide sufficient information to make a more definitive assessment. However, the lack of explicit statements about the disease mechanism and the use of variant controls weaken the evidence strength."
    },
    {
      "variant_id": {
        "Gene": "T175N",
        "Protein_Change": {
          "ref": "T",
          "alt": "N",
          "position": "175"
        },
        "variant_string_id": "T175N"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The article focuses on DJ-1 mutations and their effects on protein stability and activity",
          "judgment": "No",
          "reasoning": "No explicit statement about the disease mechanism or the function of DJ-1 within it"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper does not provide sufficient information about the disease mechanism, so we cannot evaluate the applicability of the general assay class",
          "judgment": "No",
          "reasoning": "Cannot evaluate applicability of the general assay class without knowing the disease mechanism",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not mention specific controls or replicates used in the experiments",
          "judgment": "No",
          "reasoning": "Cannot evaluate validity of specific instances of assays without information on basic controls and replicates",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The paper does not mention any specific validation studies or commercial kits used for the assays, but provides detailed methods and results, suggesting that the assays are standard techniques in the field",
          "judgment": "Yes",
          "reasoning": "Assuming that the assays are broadly accepted in the field",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "Max PS3_supporting / Max BS3_supporting"
      },
      "overall_conclusion": "The functional evidence for the T175N variant is considered Max PS3_supporting / Max BS3_supporting, as the paper does not provide sufficient information to make a more definitive assessment. However, the lack of explicit statements about the disease mechanism and the use of variant controls weaken the evidence strength."
    },
    {
      "variant_id": {
        "Gene": "L166P",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The article focuses on DJ-1 mutations and their effects on protein stability and activity",
          "judgment": "No",
          "reasoning": "No explicit statement about the disease mechanism or the function of DJ-1 within it"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper does not provide sufficient information about the disease mechanism, so we cannot evaluate the applicability of the general assay class",
          "judgment": "No",
          "reasoning": "Cannot evaluate applicability of the general assay class without knowing the disease mechanism",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not mention specific controls or replicates used in the experiments",
          "judgment": "No",
          "reasoning": "Cannot evaluate validity of specific instances of assays without information on basic controls and replicates",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The paper does not mention any specific validation studies or commercial kits used for the assays, but provides detailed methods and results, suggesting that the assays are standard techniques in the field",
          "judgment": "Yes",
          "reasoning": "Assuming that the assays are broadly accepted in the field",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "Max PS3_supporting / Max BS3_supporting"
      },
      "overall_conclusion": "The functional evidence for the L166P variant is considered Max PS3_supporting / Max BS3_supporting, as the paper does not provide sufficient information to make a more definitive assessment. However, the lack of explicit statements about the disease mechanism and the use of variant controls weaken the evidence strength."
    },
    {
      "variant_id": {
        "Gene": "A104T",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "104"
        },
        "variant_string_id": "A104T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The article focuses on DJ-1 mutations and their effects on protein stability and activity",
          "judgment": "No",
          "reasoning": "No explicit statement about the disease mechanism or the function of DJ-1 within it"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper does not provide sufficient information about the disease mechanism, so we cannot evaluate the applicability of the general assay class",
          "judgment": "No",
          "reasoning": "Cannot evaluate applicability of the general assay class without knowing the disease mechanism",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not mention specific controls or replicates used in the experiments",
          "judgment": "No",
          "reasoning": "Cannot evaluate validity of specific instances of assays without information on basic controls and replicates",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The paper does not mention any specific validation studies or commercial kits used for the assays, but provides detailed methods and results, suggesting that the assays are standard techniques in the field",
          "judgment": "Yes",
          "reasoning": "Assuming that the assays are broadly accepted in the field",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "Max PS3_supporting / Max BS3_supporting"
      },
      "overall_conclusion": "The functional evidence for the A104T variant is considered Max PS3_supporting / Max BS3_supporting, as the paper does not provide sufficient information to make a more definitive assessment. However, the lack of explicit statements about the disease mechanism and the use of variant controls weaken the evidence strength."
    },
    {
      "variant_id": {
        "Gene": "T223P",
        "Protein_Change": {
          "ref": "T",
          "alt": "P",
          "position": "223"
        },
        "variant_string_id": "T223P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The article focuses on DJ-1 mutations and their effects on protein stability and activity",
          "judgment": "No",
          "reasoning": "No explicit statement about the disease mechanism or the function of DJ-1 within it"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper does not provide sufficient information about the disease mechanism, so we cannot evaluate the applicability of the general assay class",
          "judgment": "No",
          "reasoning": "Cannot evaluate applicability of the general assay class without knowing the disease mechanism",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not mention specific controls or replicates used in the experiments",
          "judgment": "No",
          "reasoning": "Cannot evaluate validity of specific instances of assays without information on basic controls and replicates",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The paper does not mention any specific validation studies or commercial kits used for the assays, but provides detailed methods and results, suggesting that the assays are standard techniques in the field",
          "judgment": "Yes",
          "reasoning": "Assuming that the assays are broadly accepted in the field",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "Max PS3_supporting / Max BS3_supporting"
      },
      "overall_conclusion": "The functional evidence for the T223P variant is considered Max PS3_supporting / Max BS3_supporting, as the paper does not provide sufficient information to make a more definitive assessment. However, the lack of explicit statements about the disease mechanism and the use of variant controls weaken the evidence strength."
    },
    {
      "variant_id": {
        "Gene": "H126R",
        "Protein_Change": {
          "ref": "H",
          "alt": "R",
          "position": "126"
        },
        "variant_string_id": "H126R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The article focuses on DJ-1 mutations and their effects on protein stability and activity",
          "judgment": "No",
          "reasoning": "No explicit statement about the disease mechanism or the function of DJ-1 within it"
        }
      ]
    }
  ]
}